Abstract:BACKGROUND AND OBJECTIVES:Approximately 20%-30% of patients with anti-glomerular basement membrane disease present coexisting anti-myeloperoxidase (MPO) autoantibodies. We previously showed the recognition of a linear fragment of the MPO heavy chain N-terminus ((1)H, MPO279-409) in plasma from most double-positive patients. Herein, we investigated the frequency of autoantibodies against overlapping (1)H-derived linear peptides in plasma from patients with anti-glomerular basement membrane disease. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:We synthesized 13 overlapping linear peptides ((1)H-1 to (1)H-13) covering MPO279-409. We retrospectively collected plasma samples from 67 patients with anti-glomerular basement membrane disease from 1996 to 2012, and we screened them for IgG autoantibodies by ELISA using intact human MPO and the overlapping peptides as antigens, and we further investigated the clinical significance. Autoantibody binding to the linear MPO structure was confirmed by Western blotting. RESULTS:We followed up the 67 patients until 2015, with a median follow-up time of 10.0 (2.3-36.0) months, and 56 ESRD events occurred among the 67 patients with follow-up data. Plasma from 23.9% (16) of the patients recognized intact human MPO, whereas 62.7% (42) plasma samples recognized MPO279-409 linear peptides. Of the 13 linear peptides, (1)H-4 (44.8%, 30 patients) and (1)H-12 (40.3%, 27 patients) exhibited the highest recognition frequencies. Patients with autoantibodies against (1)H-11 or (1)H-12 (MPO371-400) were older (46.1±18.8 versus 34.1±16.6 years; P<0.01), had higher serum creatinine upon diagnosis (median 7.8 mg/dl, interquartile range 4.9-12.6 mg/dl versus median 5.4 mg/dl, interquartile range 2.4-7.3 mg/dl; P=0.02), and had a higher probability of progressing to ESRD; however, multivariate Cox regression analysis showed that (1)H-11 or 12 reaction was not an independent risk factor for renal failure (hazard ratio, 1.2; 95% confidence interval, 0.8 to 2.8; P=0.19). CONCLUSIONS:Autoantibodies against linear peptides of MPO can be detected in the majority of patients with anti-glomerular basement membrane disease, and several are associated with disease severity. The potential common pathogenic mechanism between anti-glomerular basement membrane antibodies and anti-MPO autoantibodies in anti-glomerular basement membrane disease requires further investigation.

Inhibition of Oxidative Activity of Myeloperoxidase by Anti-Myeloperoxidase Antibodies from Patients with Microscopic Polyangiitis

Influence of Myeloperoxidase by Anti-Myeloperoxidase Antibodies and Its Association with the Disease Activity in Microscopic Polyangiitis

Comparison of Characteristics of Natural Autoantibodies Against Myeloperoxidase and Anti-Myeloperoxidase Autoantibodies from Patients with Microscopic Polyangiitis.

Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.

IgG Subclass Distribution, Affinity of Anti‐myeloperoxidase Antibodies in Sera from Patients with Wegener's Granulomatosis and Microscopic Polyangiitis

Anti-Myeloperoxidase Antibodies In Sera From Patients With Propylthiouracil-Induced Vasculitis Might Recognize Restricted Epitopes On Myeloperoxidase Molecule

High Potential to Reverse the Inhibition of Myeloperoxidase by Ceruloplasmin of Anti-Myeloperoxidase Autoantibodies of IgG3 Subclass

[Epitope Mapping of Myeloperoxidase Antibodies in Propylthiouracil-Induced Vasculitis and Microscopic Polyangiitis].

Myeloperoxidase Influences The Complement Regulatory Function Of Modified C-Reactive Protein

Influence of Myeloperoxidase-Catalyzing Reaction on the Binding Between Myeloperoxidase and Anti-Myeloperoxidase Antibodies

Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.

Deglycosylation of myeloperoxidase uncovers its novel antigenicity.

Anti-myeloperoxidase IgG Subclass Distribution and Avidity in Sera from Patients with Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies Associated Vasculitis.

Myeloperoxidase Influences the Complement Regulatory Activity of Complement Factor H.

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort

Platelet Activation is Induced Via Myeloperoxidase Production and Anti-Myeloperoxidase Antibodies Primed by Thrombin

Inhibition of myeloperoxidase to treat left ventricular dysfunction in non-ischaemic cardiomyopathy

Deglycosylation Influences the Oxidation Activity and Antigenicity of Myeloperoxidase

Epitope Analysis of Anti-Myeloperoxidase Antibodies in Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Distribution of IgG subclass of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil induced vasculitis]

[The Relationship Between Subclassification of Anti-Myeloperoxidase IgG by Enzyme-Linked Immuno-Sorbent Assay Analysis and Vasculitis Activity].